”Seems very unlikely that nearly a year later we'd be at half still alive, just based on natural history of this cancer?”
The first point, from the language you employed was that you were dubious that half of the trial participants could not surely be still alive considering the seriousness of advanced PC and the late stage that the trial is at, not that the journalist had misinformed.
No offence but the others just seem to be of someone looking to find arguments that have been somewhat put to rest post marking.
What about the positives and what prompted you to invest in this company as per your held status which is a question not answered from previous correspondence.
- Forums
- ASX - By Stock
- OSL
- Ann: Oncosil breakthrough device receives CE Marking approval
OSL
oncosil medical ltd
Add to My Watchlist
2.00%
!
$1.02

Ann: Oncosil breakthrough device receives CE Marking approval, page-109
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.02 |
Change
0.020(2.00%) |
Mkt cap ! $14.50M |
Open | High | Low | Value | Volume |
$1.00 | $1.04 | 99.5¢ | $44.55K | 44.45K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 192 | $1.03 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.04 | 6234 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 283 | 1.025 |
1 | 550 | 1.020 |
3 | 8993 | 1.000 |
1 | 3000 | 0.990 |
1 | 1000 | 0.975 |
Price($) | Vol. | No. |
---|---|---|
1.020 | 353 | 1 |
1.050 | 25000 | 1 |
1.075 | 1879 | 1 |
1.090 | 375 | 1 |
1.120 | 6234 | 1 |
Last trade - 15.48pm 25/06/2025 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
SPONSORED BY The Market Online